FDA — authorised 28 March 2003
- Application: NDA021493
- Marketing authorisation holder: ALLERGAN
- Local brand name: ZYMAR
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
🇺🇸 gatifloxacin ophthalmic solution 0.3% in United States
FDA authorised gatifloxacin ophthalmic solution 0.3% on 28 March 2003
Marketing authorisation
Other Ophthalmology / Infectious Disease approved in United States
Frequently asked questions
Is gatifloxacin ophthalmic solution 0.3% approved in United States?
Yes. FDA authorised it on 28 March 2003.
Who is the marketing authorisation holder for gatifloxacin ophthalmic solution 0.3% in United States?
ALLERGAN holds the US marketing authorisation.